“Zoos, aquariums, conservation facilities, wildlife management organizations, and private ranches need specialized medications for some of the most beautiful and endangered creatures on our planet. Wildlife animals have medication options because we have the formulation expertise to assist zoological veterinarians when these animals become ill, develop debilitating ailments, or need to be studied or managed. Through collaborative efforts, we will continue Wildlife Pharmaceuticals’ honored tradition of formulating unique compounded medications to treat a variety of species,” Carballo said.
Carballo will report directly to Marcy Bliss, CEO of Wedgewood. Prior to Wedgewood, he spent 16 years at Henry Schein Animal Health as a territory manager and then regional manager. Before that, he was at Fort Dodge Animal Health and he began his career in accounting and sales in the health insurance industry.
Financial terms were not disclosed.